BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38772871)

  • 21. Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.
    Böhm S; Faruqi A; Said I; Lockley M; Brockbank E; Jeyarajah A; Fitzpatrick A; Ennis D; Dowe T; Santos JL; Cook LS; Tinker AV; Le ND; Gilks CB; Singh N
    J Clin Oncol; 2015 Aug; 33(22):2457-63. PubMed ID: 26124480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas.
    Dowson CB; Stewart C; O'Sullivan S; Pachter N; Schofield L; Cohen PA
    Int J Gynecol Cancer; 2020 Jan; 30(1):94-99. PubMed ID: 31699802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response.
    Zorzato PC; Zannoni GF; Tudisco R; Pasciuto T; Di Giorgio A; Franchi M; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2020 Jan; 30(1):67-73. PubMed ID: 31754067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic ovarian serous carcinoma presenting as inflammatory breast cancer: a case report.
    Gingell D; Samuel A; Haynik D; McBee W; Kelley J; Zorn K; Bhargava R
    Int J Gynecol Pathol; 2010 May; 29(3):243-7. PubMed ID: 20407323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA2-positive spinal intramedullary ovarian metastatic disease: case report.
    Ravindra VM; Mazur MD; Driscoll M; McEvoy S; Schmidt MH
    Spine J; 2016 Mar; 16(3):e201-7. PubMed ID: 26552643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.
    Lisio MA; Fu L; Goyeneche A; Gao ZH; Telleria C
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low grade serous ovarian carcinoma with metastases to the sternum and ribs.
    McGrath S; Madhuri TK; Susarla S; Haagsma B; Saleh F; Michael A
    Pathology; 2012 Aug; 44(5):481-2. PubMed ID: 22744167
    [No Abstract]   [Full Text] [Related]  

  • 28. Brain Metastases from Ovarian Carcinoma: An Evaluation of Prognostic Factors and Treatment.
    Wohl A; Kimchi G; Korach J; Perri T; Zach L; Zibly Z; Harel R; Nissim U; Spiegelmann R; Nass D; Cohen ZR
    Neurol India; 2019; 67(6):1431-1436. PubMed ID: 31857529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low grade serous ovarian carcinoma: identifying variations in practice patterns.
    Siemon J; Gershenson DM; Slomovitz B; Schlumbrecht M
    Int J Gynecol Cancer; 2019 Jan; 29(1):174-180. PubMed ID: 30640701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIPEC after neoadjuvant chemotherapy and interval debulking is associated with development of platinum-refractory or -resistant disease.
    Jou J; Zimmer Z; Charo L; Yau C; Saenz C; Eskander R; McHale M; Veerapong J; Plaxe S; Binder P
    Gynecol Oncol; 2021 Apr; 161(1):25-33. PubMed ID: 33293046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
    Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
    Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
    Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
    Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer.
    Eoh KJ; Kim HM; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    BMC Cancer; 2020 Mar; 20(1):204. PubMed ID: 32164585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.
    Kim SI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    J Ovarian Res; 2019 May; 12(1):40. PubMed ID: 31064392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
    Boyd C; McCluggage WG
    Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study.
    Lee JM; Nair J; Zimmer A; Lipkowitz S; Annunziata CM; Merino MJ; Swisher EM; Harrell MI; Trepel JB; Lee MJ; Bagheri MH; Botesteanu DA; Steinberg SM; Minasian L; Ekwede I; Kohn EC
    Lancet Oncol; 2018 Feb; 19(2):207-215. PubMed ID: 29361470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.
    Della Corte L; Giampaolino P; Fabozzi A; Cieri M; Zizolfi B; Morra I; Bifulco G
    Gynecol Endocrinol; 2019 Mar; 35(3):211-213. PubMed ID: 30449229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographic Clinical and Prognostic Factors of Primary Ovarian Adenocarcinomas of Serous and Clear Cell Histology-A Comparative Study.
    Schnack TH; Høgdall E; Nedergaard L; Høgdall C
    Int J Gynecol Cancer; 2016 Jan; 26(1):82-90. PubMed ID: 26569060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency.
    Reyes MC; Arnold AG; Kauff ND; Levine DA; Soslow RA
    Mod Pathol; 2014 Oct; 27(10):1405-11. PubMed ID: 24577588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.